Dong-A ST's biosimilar product Imuldosa approved for U.S. market
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Dong-A ST's biosimilar product Imuldosa has been approved by the U.S. Food and Drug Administration (FDA), the Korean drugmaker said Monday.
This is the second product by Dong-A ST that has received a green light from the U.S. FDA following Sivextro in 2014.
Imuldosa, which references Janssen Biotech's blockbuster drug Stelara, can be used to treat autoimmune diseases such as plague psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis, the company said.
Imuldosa has been codeveloped by Dong-A Socio Holdings and Japan's Meiji Seika Pharma since 2013 and the rights for its research and development (R&D) as well as commercialization were transferred to Dong-A ST in July 2020 for more efficiency.
In 2021, the two companies signed a global licensing agreement with U.S. Intas Pharmaceuticals which plans to commercialize the product in Europe, Britain and Canada through its subsidiaries.
"We look forward to a successful launch of Imuldosa in the United States, the world’s largest pharmaceutical market, as we continue to develop innovative medicines to further strengthen our global presence," said Dr. Park Jae-hong, head of R&D at Dong-A ST.
BY JIN EUN-SOO [jin.eunsoo@joongang.co.kr]
Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.
- Hyundai, Kia and GM Korea to recall more than 600,000 vehicles due to faulty components
- North Korea issues directive for artillery brigades as tensions with South rise
- Accident survivor finds full miracle in partial recovery
- Seoul warns of end to North Korean regime over reaction to alleged drone incursion
- ILLIT's agency denies using NewJeans' files to create girl group
- Netflix's 'Culinary Class Wars': Four contestants share 11 traditional Korean recipes for you to try
- Riize's Seunghan to 'indefinitely' halt activities due to controversial past
- Comedian Lee Jin-ho stiffs 100 million won from BTS's Jimin for gambling
- Riize’s Seunghan leaves group after fan backlash over return
- Explainer: Korea's superstores are slowly becoming grocery stores